# Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea

> **NCT06268054** · PHASE3 · NOT_YET_RECRUITING · sponsor: **EMS** · enrollment: 78 (estimated)

## Conditions studied

- Primary Dysmenorrhea

## Interventions

- **DRUG:** DEH113
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT06268054
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02
- **Primary completion:** 2027-02
- **Final completion:** 2027-09
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2024-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06268054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06268054, "Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT06268054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*